scholarly article | Q13442814 |
P356 | DOI | 10.1038/ONC.2009.507 |
P8608 | Fatcat ID | release_euztqblydbhjhmx656gszx6vom |
P698 | PubMed publication ID | 20101224 |
P2093 | author name string | D Mumberg | |
P Boukamp | |||
R Beier | |||
J Puhlmann | |||
F Puehler | |||
P2860 | cites work | The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus | Q24533256 |
Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus | Q27486638 | ||
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
How cells respond to interferons | Q27861006 | ||
Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion | Q28262533 | ||
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line | Q29547520 | ||
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor | Q29616494 | ||
Newcastle disease virus (NDV): brief history of its oncolytic strains | Q33841589 | ||
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus | Q33908950 | ||
Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1 | Q34302130 | ||
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines | Q34648125 | ||
Ras proteins: different signals from different locations | Q35120159 | ||
A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells | Q36357411 | ||
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation | Q36556010 | ||
Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection | Q37285576 | ||
Rac1 GTPase: a "Rac" of all trades. | Q37371665 | ||
Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer | Q37535829 | ||
Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation | Q38334837 | ||
Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts | Q39444795 | ||
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency. | Q39923110 | ||
Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes | Q40024329 | ||
The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells | Q40132472 | ||
Early herpes simplex virus type 1 infection is dependent on regulated Rac1/Cdc42 signalling in epithelial MDCKII cells | Q40209381 | ||
Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence | Q40318115 | ||
The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells | Q40422550 | ||
Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1. | Q40788613 | ||
Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes | Q40991506 | ||
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. | Q41147249 | ||
Defective translational control facilitates vesicular stomatitis virus oncolysis | Q42831942 | ||
Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor | Q42856274 | ||
OBSERVATIONS ON THE REPEATED ADMINISTRATION OF VIRUSES TO A PATIENT WITH ACUTE LEUKEMIA. A PRELIMINARY REPORT. | Q43786318 | ||
An optimized clinical regimen for the oncolytic virus PV701. | Q45407407 | ||
NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT. | Q45713156 | ||
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers | Q45732737 | ||
Newcastle disease virus selectively kills human tumor cells | Q45865340 | ||
Requirement for Rac1 in a K-ras induced lung cancer in the mouse | Q53329326 | ||
Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell–cell fusion | Q56912219 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | oncolytic virus | Q1560099 |
P304 | page(s) | 2205-2216 | |
P577 | publication date | 2010-01-25 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus | |
P478 | volume | 29 |